Home > Healthcare > Biotechnology > Biotechnology R&D > Gene Expression Market

Gene Expression Market Size

  • Report ID: GMI8370
  • Published Date: Mar 2024
  • Report Format: PDF

Gene Expression Market Size

Gene Expression Market size was valued at USD 12.5 billion in 2023 and is expected to grow at a CAGR of 7.1% between 2024 and 2032, propelled by factors such as the technological advancements and a growing emphasis on personalized medicine. Also, the growing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders contribute significantly to the growth of the market.

 

Altered gene expression plays a critical role in cancer development and progression. This involves activation of oncogenes and inactivation of tumor suppressor genes through various mechanisms, including genetic mutations, epigenetic modifications, and dysregulated signalling pathways. For instance, as per the Pan American Health Organization (PAHO), it is anticipated that around 20 million new cases and 10 million fatalities will arise in 2023, and annual reported cases are expected to reach about 30 million by 2040.

 

Gene expression is the process where information encoded in a gene is used to synthesize a functional gene product, such as a protein or RNA molecule. Further, gene expression analysis involves the measurement of the activity (expression) of genes in a biological sample to understand how different genes are turned on or off in response to various conditions. It aims to quantify the amount of mRNA produced from each gene, providing insights into the regulation and functioning of the genome.

 

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

The market size of gene expression reached USD 12.5 billion in 2023 and is set to witness 7.1% CAGR from 2024 to 2032, led by technological advancements and a growing emphasis on personalized medicine.

The consumables segment accounted for 46.9% of the market share in 2023, owing to its steady and regular use in gene expression experiments which are typically tailored to specific techniques or platforms.

North America market is set to exhibit robust growth between 2024 and 2032, attributed to the increased funding from government agencies, private investors, and pharmaceutical companies in the region.

Some prominent firms operating in the market are Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche Ltd., GE HealthCare Technologies, Inc., Illumina, Inc., Oxford Nanopore Technologies Ltd., Pacific Biosciences of California, Inc., PerkinElmer, Inc., Promega Corporation, Qiagen N.V., and Thermo Fisher Scientific Inc.

Gene Expression Market Scope

Buy Now


Premium Report Details

  • Base Year: 2023
  • Companies covered: 11
  • Tables & Figures: 381
  • Countries covered: 19
  • Pages: 230
 Download Free Sample